Aug
21
2025
Monument Therapeutics to trial schizophrenia therapy in partnership with FNIH
U K-based Monument Therapeutics has partnered with the US Foundation for the National Institutes of Health (FNIH) to study MT1988, which is under development for treating cognitive impairment in …
